These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 84042)

  • 1. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
    J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens.
    Baker CJ; Kasper DL; Edwards MS; Schiffman G
    N Engl J Med; 1980 Jul; 303(4):173-8. PubMed ID: 6155612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Fischer GW; Lowell GH; Crumrine MH; Wilson SR
    Lancet; 1979 Jan; 1(8107):75-7. PubMed ID: 84130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Fischer GW; Hunter KW; Wilson SR
    Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.
    Fischer GW; Lowell GH; Crumrine MH; Bass JW
    J Exp Med; 1978 Sep; 148(3):776-86. PubMed ID: 29937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
    Baker CJ; Edwards MS; Kasper DL
    Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.
    Schifferle RE; Jennings HJ; Wessels MR; Katzenellenbogen E; Roy R; Kasper DL
    J Immunol; 1985 Dec; 135(6):4164-70. PubMed ID: 3934276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines.
    Colling RG; Pearson TC; Brown JC
    Infect Immun; 1983 Jul; 41(1):205-13. PubMed ID: 6345390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.
    Baker CJ; Kasper DL
    J Infect Dis; 1977 Aug; 136 Suppl():S98-104. PubMed ID: 70493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
    Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
    N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.
    Kasper DL; Baker CJ; Galdes B; Katzenellenbogen E; Jennings HJ
    J Clin Invest; 1983 Jul; 72(1):260-9. PubMed ID: 6192144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
    Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
    Edwards MS; Fuselier PA; Rench MA; Kasper DL; Baker CJ
    Infect Immun; 1984 May; 44(2):257-61. PubMed ID: 6370863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
    Edwards MS; Baker CJ; Kasper DL
    J Infect Dis; 1979 Dec; 140(6):1004-8. PubMed ID: 396335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus.
    Baker CJ; Webb BJ; Kasper DL; Yow MD; Beachler CW
    Am J Obstet Gynecol; 1980 May; 137(1):39-42. PubMed ID: 6989248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group B streptococcal vaccines.
    Baker CJ; Kasper DL
    Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble group- and type-specific antigens from type III group B Streptococcus.
    Carey RB; Eisenstein TK; Shockman GD; Greber TF; Swenson RM
    Infect Immun; 1980 Apr; 28(1):195-203. PubMed ID: 6155346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.